There are disclosed compounds of the formula ##STR1## wherein Y represents ##STR2## R and R.sup.1 are each, independently, hydrogen, lower alkyl, phenyl or naphthyl, with that proviso that when R and R.sup.1 are both phenyl, R.sup.2 is other than phenyl; Z is ##STR3## R.sup.2 is 2-pyrimidinyl, halopyrimidin-2-yl, 2-pyridinyl, halopyridin-2-yl, cyanopyridin-2-yl, phenyl or phenyl substituted with lower alkyl, halo or trifluoromethyl; R.sup.3 is phenyl or phenyl substituted with halo or trifluoromethyl; m is 2-7; n is 2-5; and and the pharmaceutically acceptable salts thereof and their use as antipsychotic/anxiolytic agents having a low liability for extrapyramidal side effects.
公开了化合物的式子 ##STR1## 其中,Y代表 ##STR2## R和R.sup.1各自独立地代表氢,低级烷基,苯基或
萘基,但当R和R.sup.1都是苯基时,R.sup.2不是苯基;Z代表 ##STR3## R.sup.2是2-
嘧啶基,卤代
嘧啶-2-基,2-
吡啶基,卤代
吡啶-2-基,
氰基吡啶-2-基,苯基或被低级烷基,卤素或三
氟甲基取代的苯基;R.sup.3是苯基或被卤素或三
氟甲基取代的苯基;m为2-7;n为2-5;以及其药学上可接受的盐,以及它们作为具有低额外锥体副作用的抗精神病/抗焦虑剂的用途。